2020 Updates on SCLC: Have We Progressed in the Treatment of Relapsed Disease? Is FDA-Approved Lurbinectedin a New SoC? Are Pembro & Nivo Beneficial Options for ES & PDL1 Patients?

By GRACE FEATURING Taofeek Owonikoko
By GRACE FEATURING Taofeek Owonikoko
226 views
November 27, 2020
Comments 0
Login to view comments. Click here to Login